E-LIB Suche - Ergebnisse für: Jurczak, Wojciech

1

Mutational profile of previously treated chronic lymphocyti..:

Woyach, Jennifer A. ; Jones, Daniel ; Jurczak, Wojciech...
Blood Journal. , 2024

Link: https://doi.org/10.1182/..

2

A phase 2 study of the PI3Kδ inhibitor parsaclisib in relap..:

Phillips, Tycel J. ; Avigdor, Abraham ; Gurion, Ronit...
Blood Advances. 8 (2024) 4 - p. 867-877 , 2024

Link: https://doi.org/10.1182/..

3

Characterization of zanubrutinib safety and tolerability pr..:

Brown, Jennifer R. ; Ghia, Paolo ; Jurczak, Wojciech...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

4

Plain language summary of zanubrutinib or ibrutinib in chro..:

Brown, Jennifer R ; Eichhorst, Barbara ; Hillmen, Peter...
Future Oncology. 20 (2024) 12 - p. 717-726 , 2024

Link: https://doi.org/10.2217/..

5

Deep and Durable Responses with Epcoritamab SC Monotherapy ..:

Linton, Kim M ; Jurczak, Wojciech ; Lugtenburg, Pieternella J....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S33-S34 , 2024

Link: https://doi.org/10.1016/..

6

Acalabrutinib plus venetoclax and rituximab in treatment-na..:

Wang, Michael L ; Robak Prof., Tadeusz ; Maddocks, Kami J...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

7

Acalabrutinib-based regimens in frontline or relapsed/refra..:

Davids, Matthew S ; Sharman, Jeff P. ; Ghia, Paolo...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

8

Epcoritamab monotherapy in patients with relapsed or refrac..:

Linton, Kim M ; Vitolo, Umberto ; Jurczak, Wojciech...
The Lancet Haematology. , 2024

Link: https://doi.org/10.1016/..

9

Safety of extended pirtobrutinib exposure in relapsed and/o..:

Roeker, Lindsey E. ; Coombs, Catherine C. ; Shah, Nirav N....
Acta Haematologica. , 2024

Link: https://doi.org/10.1159/..

10

Biomarker analysis of the ASPEN study comparing zanubrutini..:

Tam, Constantine S. ; Opat, Stephen ; D'Sa, Shirley...
Blood Advances. 8 (2024) 7 - p. 1639-1650 , 2024

Link: https://doi.org/10.1182/..

11

Higher Mortality in Patients With Diffuse Large B-cell Lymp..:

Szmit, Sebastian ; Długosz-Danecka, Monika ; Drozd-Sokołowska, Joanna...
Heart, Lung and Circulation. 33 (2024) 5 - p. 675-683 , 2024

Link: https://doi.org/10.1016/..

12

CT-168 Comparison of Bleeding-Related Events in Patients Wh..:

Konig, Heiko ; Tam, Constantine S. ; Lamanna, Nicole...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S520-S521 , 2023

Link: https://doi.org/10.1016/..

13

P1088: COMPARISON OF BLEEDING-RELATED EVENTS IN PATIENTS WH..:

Lamanna, Nicole ; Tam, Constantine ; Jurczak, Wojciech...
HemaSphere. 7 (2023) S3 - p. e724362f , 2023

Link: https://doi.org/10.1097/..

14

POSTER: ABCL-450 Five-Year Efficacy and Safety of Tafasitam..:

Duell, Johannes ; Abrisqueta, Pau ; Andre, Marc...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S206 , 2023

Link: https://doi.org/10.1016/..

15

Oral Abstract: ABCL-500 Longer Follow-Up Reaffirms Subcutan..:

Karimi, Yasmin ; Ghesquieres, Herve ; Jurczak, Wojciech...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S147 , 2023

Link: https://doi.org/10.1016/..